Your patient is being induced and is currently on 18 mu/min of oxytocin. The tracing shows a baseline of 145 bpm with moderate variability, but you notice three late decels. What is your BEST next step?

Prepare for the FHR Monitoring V2 Test with flashcards and multiple choice questions, each question comes with hints and explanations. Boost your readiness for the exam today!

Multiple Choice

Your patient is being induced and is currently on 18 mu/min of oxytocin. The tracing shows a baseline of 145 bpm with moderate variability, but you notice three late decels. What is your BEST next step?

In the scenario where a patient on oxytocin shows a baseline fetal heart rate of 145 bpm with moderate variability and three late decelerations, the best next step is to reduce the oxytocin dosage and notify the provider. Late decelerations often indicate uteroplacental insufficiency, whereby the fetus is not receiving adequate oxygen due to issues with placental function during contractions. Reducing the oxytocin infusion is an appropriate intervention as it allows for a decrease in uterine contractions, which may improve placental blood flow and oxygenation to the fetus. This approach helps mitigate the risk of fetal distress while also giving the healthcare provider the chance to assess the situation more thoroughly. Notifying the provider is essential to ensure that they are aware of the monitoring results and the actions taken, allowing for potential further interventions to safeguard the well-being of both the mother and the fetus. This step emphasizes collaborative care in managing labor and delivery. Other options may not address the immediacy of the situation as effectively. Stopping pitocin might be a valid consideration, but reducing the dose while retaining some uterine activity can strike a balance between managing contractions and allowing for assessment of the fetal response. The requests for amnioinfusion or internal monitoring are

In the scenario where a patient on oxytocin shows a baseline fetal heart rate of 145 bpm with moderate variability and three late decelerations, the best next step is to reduce the oxytocin dosage and notify the provider.

Late decelerations often indicate uteroplacental insufficiency, whereby the fetus is not receiving adequate oxygen due to issues with placental function during contractions. Reducing the oxytocin infusion is an appropriate intervention as it allows for a decrease in uterine contractions, which may improve placental blood flow and oxygenation to the fetus. This approach helps mitigate the risk of fetal distress while also giving the healthcare provider the chance to assess the situation more thoroughly.

Notifying the provider is essential to ensure that they are aware of the monitoring results and the actions taken, allowing for potential further interventions to safeguard the well-being of both the mother and the fetus. This step emphasizes collaborative care in managing labor and delivery.

Other options may not address the immediacy of the situation as effectively. Stopping pitocin might be a valid consideration, but reducing the dose while retaining some uterine activity can strike a balance between managing contractions and allowing for assessment of the fetal response. The requests for amnioinfusion or internal monitoring are

More practice questions